To evaluate the effect of Metoclopramide -a prokinetic and anti emetic drug on the gastric volume after adequate fasting in patients undergoing gynaecological surgeries after spinal anaesthesia
Not Applicable
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: N819- Female genital prolapse, unspecifiedHealth Condition 3: N72- Inflammatory disease of cervix uteri
- Registration Number
- CTRI/2024/04/066529
- Lead Sponsor
- Dr RPGMC Kangra at Tanda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA class I and II
BMI 18.5 – 29.9 kg/m2
Mallampati I or II
Exclusion Criteria
1.Patients’ refusal for SAB
2. Patients with cardiovascular or respiratory disorders, diabetes, hypertension
3.Obesity( BMI >29.9kg/m2)
4.Abnormality of upper gastrointestinal tract(GIT) and history of GIT related surgical procedures in the past
5.Use of drugs affecting gastric motility
6. Need for general anaesthesia (GA) due to partial effect of SAB
7.Any contraindication to SAB
8.Cognitive impaired patients
9.History of prolonged QT interval or neuropsychiatric illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method